UCSF home page UCSF home page About UCSF Search UCSF UCSF Medical Center
UCSF navigation bar
  UCSF arrow indicating deeper hierarchy A-Z Index of Webs arrow indicating deeper hierarchy U arrow indicating deeper hierarchyDepartment of Urology arrow indicating deeper hierarchyFaculty arrow indicating deeper hierarchy John Kurhanewicz, PhD  
Department of Urology   search
Department of Urology

John Kurhanewicz, PhD

Recent Publications

Publications – 2008

Albers, M.J., R. Bok, A.P. Chen, C.H. Cunningham, M.L. Zierhut, V.Y. Zhang, S.J. Kohler, J. Tropp, R.E. Hurd, Y.F. Yen, S.J. Nelson, D.B. Vigneron, and J. Kurhanewicz, Hyperpolarized 13C lactate, pyruvate, and alanine: noninvasive biomarkers for prostate cancer detection and grading. Cancer Res, 2008. 68(20): p. 8607-15.
Cabrera, A.R., F.V. Coakley, A.C. Westphalen, Y. Lu, S. Zhao, K. Shinohara, P.R. Carroll, and J. Kurhanewicz, Prostate cancer: is inapparent tumor at endorectal MR and MR spectroscopic imaging a favorable prognostic finding in patients who select active surveillance? Radiology, 2008. 247(2): p. 444-50.
Chen, A.P., J. Kurhanewicz, R. Bok, D. Xu, D. Joun, V. Zhang, S.J. Nelson, R.E. Hurd, and D.B. Vigneron, Feasibility of using hyperpolarized [1-13C]lactate as a substrate for in vivo metabolic 13C MRSI studies. Magn Reson Imaging, 2008. 26(6): p. 721-6.
Chen, A.P., J. Tropp, R.E. Hurd, M.V. Criekinge, L.G. Carvajal, D. Xu, J. Kurhanewicz, and D.B. Vigneron, In vivo hyperpolarized (13)C MR spectroscopic imaging with (1)H decoupling. J Magn Reson, 2008.
Cunningham, C.H., A.P. Chen, M. Lustig, B.A. Hargreaves, J. Lupo, D. Xu, J. Kurhanewicz, R.E. Hurd, J.M. Pauly, S.J. Nelson, and D.B. Vigneron, Pulse sequence for dynamic volumetric imaging of hyperpolarized metabolic products. J Magn Reson, 2008. 193(1): p. 139-46.
Hu, S., M. Lustig, A.P. Chen, J. Crane, A. Kerr, D.A. Kelley, R. Hurd, J. Kurhanewicz, S.J. Nelson, J.M. Pauly, and D.B. Vigneron, Compressed sensing for resolution enhancement of hyperpolarized 13C flyback 3D-MRSI. J Magn Reson, 2008. 192(2): p. 258-64.
Joe, B.N., K. Vahidi, A. Zektzer, M.H. Chen, M.S. Clifton, T. Butler, K. Keshari, J. Kurhanewicz, F. Coakley, and M.G. Swanson, (1)H HR-MAS spectroscopy for quantitative measurement of choline concentration in amniotic fluid as a marker of fetal lung maturity: inter- and intraobserver reproducibility study. J Magn Reson Imaging, 2008. 28(6): p. 1540-5.
Joseph, T., D.A. McKenna, A.C. Westphalen, F.V. Coakley, S. Zhao, Y. Lu, I.C. Hsu, M. Roach, 3rd, and J. Kurhanewicz, Pretreatment Endorectal Magnetic Resonance Imaging and Magnetic Resonance Spectroscopic Imaging Features of Prostate Cancer as Predictors of Response to External Beam Radiotherapy. Int J Radiat Oncol Biol Phys, 2008.
Keshari, K.R., J.C. Lotz, T.M. Link, S. Hu, S. Majumdar, and J. Kurhanewicz, Lactic Acid and Proteoglycans as Metabolic Markers for Discogenic Back Pain. Spine, 2008. 33(3): p. 312-317.
Kim, D.H., K. Vahidi, A.B. Caughey, F.V. Coakley, D.B. Vigneron, J. Kurhanewicz, B. Mow, and B.N. Joe, In vivo (1)H magnetic resonance spectroscopy of amniotic fluid and fetal lung at 1.5 T: technical challenges. J Magn Reson Imaging, 2008. 28(4): p. 1033-8.
Kim, Y., I.C. Hsu, E. Lessard, J. Kurhanewicz, S.M. Noworolski, and J. Pouliot, Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI. Radiother Oncol, 2008. 88(1): p. 148-55.
Kurhanewicz, J., R. Bok, S.J. Nelson, and D.B. Vigneron, Current and potential applications of clinical 13C MR spectroscopy. J Nucl Med, 2008. 49(3): p. 341-4.
Kurhanewicz, J., D. Vigneron, P. Carroll, and F. Coakley, Multiparametric magnetic resonance imaging in prostate cancer: present and future. Curr Opin Urol, 2008. 18(1): p. 71-7.
Kurhanewicz, J. and D.B. Vigneron, Advances in MR spectroscopy of the prostate. Magn Reson Imaging Clin N Am, 2008. 16(4): p. 697-710, ix-x.
Larson, P.E., A.B. Kerr, A.P. Chen, M.S. Lustig, M.L. Zierhut, S. Hu, C.H. Cunningham, J.M. Pauly, J. Kurhanewicz, and D.B. Vigneron, Multiband excitation pulses for hyperpolarized 13C dynamic chemical-shift imaging. J Magn Reson, 2008. 194(1): p. 121-7.
McKenna, D.A., F.V. Coakley, A.C. Westphalen, S. Zhao, Y. Lu, E.M. Webb, B. Pickett, M. Roach, 3rd, and J. Kurhanewicz, Prostate Cancer: Role of Pretreatment MR in Predicting Outcome after External-Beam Radiation Therapy--Initial Experience. Radiology, 2008.
Noworolski, S.M., J.C. Crane, D.B. Vigneron, and J. Kurhanewicz, A clinical comparison of rigid and inflatable endorectal-coil probes for MRI and 3D MR spectroscopic imaging (MRSI) of the prostate. J Magn Reson Imaging, 2008. 27(5): p. 1077-82.
Noworolski, S.M., D.B. Vigneron, A.P. Chen, and J. Kurhanewicz, Dynamic contrast-enhanced MRI and MR diffusion imaging to distinguish between glandular and stromal prostatic tissues. Magn Reson Imaging, 2008. 26(8): p. 1071-80.
Swanson, M.G., K.R. Keshari, Z.L. Tabatabai, J.P. Simko, K. Shinohara, P.R. Carroll, A.S. Zektzer, and J. Kurhanewicz, Quantification of choline- and ethanolamine-containing metabolites in human prostate tissues using 1H HR-MAS total correlation spectroscopy. Magn Reson Med, 2008. 60(1): p. 33-40.
Tessem, M.B., M.G. Swanson, K.R. Keshari, M.J. Albers, D. Joun, Z.L. Tabatabai, J.P. Simko, K. Shinohara, S.J. Nelson, D.B. Vigneron, I.S. Gribbestad, and J. Kurhanewicz, Evaluation of lactate and alanine as metabolic biomarkers of prostate cancer using 1H HR-MAS spectroscopy of biopsy tissues. Magn Reson Med, 2008. 60(3): p. 510-6.
Umbehr, M., L.M. Bachmann, U. Held, T.M. Kessler, T. Sulser, D. Weishaupt, J. Kurhanewicz, and J. Steurer, Combined Magnetic Resonance Imaging and Magnetic Resonance Spectroscopy Imaging in the Diagnosis of Prostate Cancer: A Systematic Review and Meta-analysis. Eur Urol, 2008.
Westphalen, A.C., F.V. Coakley, A. Qayyum, M. Swanson, J.P. Simko, Y. Lu, S. Zhao, P.R. Carroll, B.M. Yeh, and J. Kurhanewicz, Peripheral zone prostate cancer: accuracy of different interpretative approaches with MR and MR spectroscopic imaging. Radiology, 2008. 246(1): p. 177-84.
Westphalen, A.C., D.A. McKenna, J. Kurhanewicz, and F.V. Coakley, Role of magnetic resonance imaging and magnetic resonance spectroscopic imaging before and after radiotherapy for prostate cancer. J Endourol, 2008. 22(4): p. 789-94.
 

Publications – 2007

Chen, A.P., M.J. Albers, C.H. Cunningham, S.J. Kohler, Y.F. Yen, R.E. Hurd, J. Tropp, R. Bok, J.M. Pauly, S.J. Nelson, J. Kurhanewicz, and D.B. Vigneron, Hyperpolarized C-13 spectroscopic imaging of the TRAMP mouse at 3T-Initial experience. Magn Reson Med, 2007. 58(6): p. 1099-106.
Chen, A.P., C.H. Cunningham, E. Ozturk-Isik, D. Xu, R.E. Hurd, D.A. Kelley, J.M. Pauly, J. Kurhanewicz, S.J. Nelson, and D.B. Vigneron, High-speed 3T MR spectroscopic imaging of prostate with flyback echo-planar encoding. J Magn Reson Imaging, 2007. 25(6): p. 1288-92.
Coakley, F.V., I. Chen, A. Qayyum, A.C. Westphalen, P.R. Carroll, H. Hricak, M.H. Chen, and J. Kurhanewicz, Validity of prostate-specific antigen as a tumour marker in men with prostate cancer managed by watchful-waiting: correlation with findings at serial endorectal magnetic resonance imaging and spectroscopic imaging. BJU Int, 2007. 99(1): p. 41-5.
Costouros, N.G., F.V. Coakley, A.C. Westphalen, A. Qayyum, B.M. Yeh, B.N. Joe, and J. Kurhanewicz, Diagnosis of prostate cancer in patients with an elevated prostate-specific antigen level: role of endorectal MRI and MR spectroscopic imaging. AJR Am J Roentgenol, 2007. 188(3): p. 812-6.
Cunningham, C.H., A.P. Chen, M.J. Albers, J. Kurhanewicz, R.E. Hurd, Y.F. Yen, J.M. Pauly, S.J. Nelson, and D.B. Vigneron, Double spin-echo sequence for rapid spectroscopic imaging of hyperpolarized 13C. J Magn Reson, 2007. 187(2): p. 357-62.
Hom, J.J., F.V. Coakley, J.P. Simko, Y. Lu, A. Qayyum, A.C. Westphalen, L.D. Schmitt, P.R. Carroll, and J. Kurhanewicz, High-grade prostatic intraepithelial neoplasia in patients with prostate cancer: MR and MR spectroscopic imaging features--initial experience. Radiology, 2007. 242(2): p. 483-9.
Kim, Y., I.C. Hsu, E. Lessard, J. Kurhanewicz, S.M. Noworolski, and J. Pouliot, Class solution in inverse planned HDR prostate brachytherapy for dose escalation of DIL defined by combined MRI/MRSI. Radiother Oncol, 2007.
Kohler, S.J., Y. Yen, J. Wolber, A.P. Chen, M.J. Albers, R. Bok, V. Zhang, J. Tropp, S. Nelson, D.B. Vigneron, J. Kurhanewicz, and R.E. Hurd, In vivo 13 carbon metabolic imaging at 3T with hyperpolarized 13C-1-pyruvate. Magn Reson Med, 2007. 58(1): p. 65-9.
Mueller-Lisse, U.G., M.G. Swanson, D.B. Vigneron, and J. Kurhanewicz, Magnetic resonance spectroscopy in patients with locally confined prostate cancer: association of prostatic citrate and metabolic atrophy with time on hormone deprivation therapy, PSA level, and biopsy Gleason score. Eur Radiol, 2007. 17(2): p. 371-8.
Rajesh, A., F.V. Coakley, and J. Kurhanewicz, 3D MR spectroscopic imaging in the evaluation of prostate cancer. Clin Radiol, 2007. 62(10): p. 921-9.
Testa, C., R. Schiavina, R. Lodi, E. Salizzoni, B. Corti, M. Farsad, J. Kurhanewicz, F. Manferrari, E. Brunocilla, C. Tonon, N. Monetti, P. Castellucci, S. Fanti, M. Coe, W.F. Grigioni, G. Martorana, R. Canini, and B. Barbiroli, Prostate cancer: sextant localization with MR imaging, MR spectroscopy, and 11C-choline PET/CT. Radiology, 2007. 244(3): p. 797-806.